Global Active Pharmaceutical Ingredients Market

According to the report title “Global Active Pharmaceutical Ingredients Market Outlook, 2027”, published by Bonafide Research. The global active pharmaceutical ingredients market size was valued at USD 187.2 billion in 2020 and is expected to expand at a CAGR of more than 6.8% from 202

Global Active Pharmaceutical Ingredients Market is expected to grow with the CAGR of more than 6.8% by 2027

Active pharmaceutical ingredients and excipients are the two most important ingredients in the production of a medicine. The API is the active ingredient in the medicine, whereas the excipient is a substance that isn't the drug but acts as a medium to aid in its absorption by the body. The API is created by a series of chemical reactions rather than a single reaction from the raw components. An intermediate is a chemical compound that is in the process of creating an API from a raw source. It is purified until it reaches a very high degree of purity and then becomes an API after this lengthy production procedure. To test the strength of a medicine on humans or in laboratory circumstances, every drug must first receive FDA approval.

According to the report title “Global Active Pharmaceutical Ingredients Market Outlook, 2027”, published by Bonafide Research. The global active pharmaceutical ingredients market size was valued at USD 187.2 billion in 2020 and is expected to expand at a CAGR of more than 6.8% from 2021 to 2027.

To avail the sample report for free: https://www.bonafideresearch.com/samplereport/220379971/global-active-pharmaceutical-ingredients-market

API is used widely in various therapeutic applications like oncology, CVD, respiratory disease, infectious disease, diabetes pain management, etc. The oncology segment is expected to grow with the highest CAGR of 8.4% because of the emerging demand of High Potent APIs for cancer treatment. Although, cardiovascular disease covers huge market shares in terms of value. The market is divided into two segments by the API type, i.e., branded generic APIs. The branded API dominated the market share in 2020. Due to the expiration of branded drug patents, the generic APIs segment is expected to grow rapidly during the forecast period. Also, unmet clinical needs in developing countries increased acceptance of OTC drugs, and lower generic drug costs drive the generic segment. The generic API contains the same chemical substance but differs in taste, color, packaging process, or manufacturing ingredients.

The active pharmaceutical ingredients market is segmented into two divisions by manufacturing type i.e. captive and merchant. The captive APIs contributes the major market share because the parameters of manufacturing are affordable comparatively. The APIs are generally synthesis by two methods. One of them is synthetic API which has huge market share captured. On the other hand the biotech APIs are very advanced in terms of treating as desired. Deaths all over the world are caused by cardiovascular disease (32%), cancer, respiratory disease, diabetes and other diseases. The rising number in geriatric population growing RD department of treatment for disease are the drivers for the market growth in the forecast period. Besides, the increasing complexity of chronic diseases, as well as the increased frequency of new instances, has led to a significant increase in demand for innovative drugs, particularly biological therapeutics.

The North America is leading the global active pharmaceutical ingredients market with 37.8% share. As USA is the worldwide leader in per capita prescription drug spending. Asia-pacific is the fastest growing region among all in the active pharmaceutical ingredients. As the developing countries like China, Japan India are the core reasons for that. China has no comparison in manufacturing APIs in terms of pricing India had made its own remarkable position in generic market. India, which is one of the world's largest producers of the anti-malarial drug hydroxychloroquine (HCQ), has mysteriously become the world's savior. This generic drug is used to counter the Sars-Cov2 virus and is thus in high demand.

COVID-19 Impact:
As the Covid-19 pandemic had resulted into strict lockdown and shut down of many companies majorly in Asia-Pacific impacted global active pharmaceutical ingredients. The y-o-y growth in global APIs market was not met in 2020 as the lack of raw material supply chain labor. Although the demand for the drugs likes paracetamol, azithromycin and hydroxychloroquine is up taking the charge. To treat the symptoms and numerous health conditions that a COVID-19 patient may have, such as cough, cold high fever, a variety of medications are employed, leading to the pharmaceutical industry being the epicenter of the pandemic.

Major Companies present in the market:
Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Limited, Lupin Limited, Sun Pharmaceutical Industries Limited, Pfizer Inc., Novartis International AG, Biocon Limited, Sanofi S.A., Teva Pharmaceutical Industries Limited, AbbVie Inc., GlaxoSmithKline plc., Merck Co., Inc., Viatris Inc., Bristol-Myers Squibb Company

Considered in this report
  • Geography: Global
  • Historic Year: 2016
  • Base year: 2021
  • Estimated year: 2022
  • Forecast year: 2027

Aspects covered in this report
  • Global Active Pharmaceutical Ingredients Market with its value and forecast along with its segments
  • Region country wise Active Pharmaceutical Ingredients market analysis
  • Application wise Active Pharmaceutical Ingredients distribution
  • Various drivers and challenges
  • On-going trends and developments
  • Top profiled companies
  • Strategic recommendation

Regions covered in the report
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle-East Africa

Based on synthesis of Active Pharmaceutical Ingredients in the report:
• Synthetic APIs
• Biotech APIs

Based on drug type of Active Pharmaceutical Ingredients in the report:
• Branded APIs
• Generic APIs

Based on type of manufacture of Active Pharmaceutical Ingredients in the report:
• Captive APIs
• Merchant APIs

By Therapeutic Application Type in the report:
• Communicable Diseases
• Oncology
• Diabetes
• Cardiovascular Disease
• Pain management
• Respiratory Diseases
• Other Therapeutic Applications

Table of Contents

1. Executive Summary
2. Report Methodology
3. Market Structure
3.1. Market Considerate
3.2. Market Definition
4. Economic /Demographic Snapshot
5. Top 10 Pharmaceutical Markets Worldwide, 2020
6. Global Active Pharmaceutical Ingredients Market Outlook
6.1. Market Size By Value
6.2. Market Share
6.2.1. By Region
6.2.2. By Country
6.2.3. By Synthesis Type
6.2.4. By Type of Manufacture
6.2.5. By API Type
6.2.6. By Drug Type
6.2.7. By Therapeutic Application
…continue

To Access Complete Report: https://www.bonafideresearch.com/product/220379971/global-active-pharmaceutical-ingredients-market

Contact Us:
Bonafide Research
Steven Thomas, AM - Content Marketing
sales@bonafideresearch.com
Asia-Pacific: +91 7878231309 / +61 2 8091 2123
Europe: +44 20 8089 0049
North America: +1 201 793 8545  

https://www.bonafideresearch.com/

About us: Bonafide Research is one of the fastest growing market research and consulting company. We are expert in syndicated research reports custom research solutions across the domains. We have been closely working with fortune 500 clients by helping them in tracking the constantly changing market scenarios.

 

 

 


Martin Issac

25 Blog posts

Comments